Related Experiment Video
Updated: Jun 8, 2025
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Statin use and ovarian cancer outcomes
John P Micha1, Mark A Rettenmaier1, Randy D Bohart2
1Department f Breast and Gynecologic Cancers, Women's Cancer Research Foundation, Laguna Beach, CA, USA.
Introduction:
Ovarian cancer contributed to 13,270 patient deaths in the United States during 2023 and is considered the most aggressive gynecologic malignancy. While surgery, chemotherapy and targeted medications have improved ovarian cancer patient outcomes, novel therapies that further bolster treatment efficacy without compromising toxicity represent an unmet clinical need.
Areas Covered:
In the current review, we assessed the reported studies involving statin use and ovarian cancer outcomes; a preponderance of the evidence indicated that statins confer a survival benefit in ovarian cancer, especially for patients who underwent treatment post-diagnosis and for a prolonged interval.
Expert Opinion:
The evidence involving a potential survival benefit from statin use in ovarian cancer remains controversial, especially with hydrophilic statins (e.g. pravastatin). While statin users may exhibit better ovarian cancer survival outcomes than non-statin users, additional research should evaluate the putative clinical benefits of statins in ovarian cancer via randomized controlled trials.
Insights
Statins may improve survival for ovarian cancer patients, particularly those treated long-term post-diagnosis. Further research is needed to confirm these benefits in rigorous clinical trials.
Area of Science:
- Gynecologic Oncology
- Pharmacology
Background:
- Ovarian cancer is a highly aggressive malignancy with significant mortality.
- Current treatments (surgery, chemotherapy) have limitations, creating a need for novel therapies.
Purpose of the Study:
- To review existing literature on statin use and its impact on ovarian cancer outcomes.
- To evaluate the potential survival benefits of statins in ovarian cancer patients.
Main Methods:
- Systematic review of reported studies examining statin use and ovarian cancer.
- Analysis of evidence regarding survival benefits associated with statin therapy.
Main Results:
- A majority of evidence suggests statins may offer a survival advantage in ovarian cancer.
- This benefit appears more pronounced in patients treated post-diagnosis and for extended periods.
Conclusions:
- Statin use may be associated with improved survival in ovarian cancer patients.
- Evidence remains controversial, particularly for hydrophilic statins.
- Randomized controlled trials are necessary to definitively establish the clinical benefits of statins in ovarian cancer.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:21Cancer Survival Analysis
02:07Oogenesis